Cytokine-mediated Down-regulation of CYP1A1 in Hepa1 Cells

Gonzalez, 1990, Molecular genetics of the P450 superfamily, Pharmacol Ther, 45, 1, 10.1016/0163-7258(90)90006-N

Muntané-Relat, 1995, Differential effects of cytokines on the inducible expression of CYP1A1, CYP1A2, and CYP3A4 in human hepatocytes in primary culture, Hepatology, 22, 1143, 10.1002/hep.1840220420

Chang, 1978, Altered theophylline pharmacokinetics during acute respiratory viral illness, Lancet, 1, 1132, 10.1016/S0140-6736(78)90305-7

Renton, 1976, Depression of hepatic cytochrome P-450-dependent monooxygenase systems with administered interferon inducing agents, Biochem Biophys Res Commun, 73, 343, 10.1016/0006-291X(76)90713-0

Renton, 1981, Depression of hepatic cytochrome P-450-dependent mixed function oxidases during infection with encephalomyocarditis virus, Biochem Pharmacol, 30, 2333, 10.1016/0006-2952(81)90107-6

Stanley, 1988, Potentiation and suppression of mouse liver cytochrome P-450 isozymes during the acute-phase response induced by bacterial endotoxin, Eur J Biochem, 174, 31, 10.1111/j.1432-1033.1988.tb14058.x

Gorodischer, 1976, Hepatic microsomal drug metabolism after administration of endotoxin in rats, Biochem Pharmacol, 25, 351, 10.1016/0006-2952(76)90226-4

Ghezzi, 1986, Role of interleukin-1 in the depression of liver drug metabolism by endotoxin, Infect Immun, 54, 837, 10.1128/IAI.54.3.837-840.1986

Barker, 1992, Interleukin-1β suppresses the induction of P4501A1 and P4501A2 mRNAs in isolated hepatocytes, J Biol Chem, 267, 8050, 10.1016/S0021-9258(18)42406-4

Poüs, 1990, Effect of recombinant human interleukin-1β and tumor necrosis factor α on liver cytochrome P-450 and serum α-1-acid glycoprotein concentrations in the rat, Drug Metab Dispos, 18, 467

Williams, 1991, Effect of interleukin 6 on phenobarbital induction of cytochrome P-450IIB in cultured rat hepatocytes, Biochem Biophys Res Commun, 178, 1049, 10.1016/0006-291X(91)90998-M

Fukuda, 1992, Interleukin-6 down regulates the expression of transcripts encoding cytochrome P450 IA1, IA2, and IIIA3 in human hepatoma cells, Biochem Biophys Res Commun, 184, 960, 10.1016/0006-291X(92)90684-D

Abdel-Razzak, 1993, Cytokines down-regulate expression of major cytochrome P450 enzymes in adult human hepatocytes in primary culture, Mol Pharmacol, 44, 707

Fukuda, 1994, Suppression of cytochrome P450IA1 by interleukin-6 in human HepG2 hepatoma cells, Biochem Pharmacol, 47, 1187, 10.1016/0006-2952(94)90391-3

Clark, 1995, Differential effect of cytokines on the phenobarbital or 3-methylcholanthrene induction of P450 mediated monooxygenase activity in cultured rat hepatocytes, Biochem Pharmacol, 49, 97, 10.1016/0006-2952(94)00438-R

Carlson, 1996, Role of nitric oxide in the cytokine-mediated regulation of cytochrome P450, Mol Pharmacol, 49, 796

Burke, 1977, Characteristics of a microsomal cytochrome P-448-mediated reaction, Drug Metab Dispos, 5, 1

Lowry, 1951, Protein measurement with the Folin phenol reagent, J Biol Chem, 193, 265, 10.1016/S0021-9258(19)52451-6

Chun, 1994, Suppression of TCDD-induced cytochrome P450IA1 activity by staurosporine in mouse primary hepatocyte cultures and hepatoma cells, Biochem Mol Biol Int, 32, 1023

Smith, 1994, SDS polyacrylamide gel electrophoresis of proteins, Vol. 32, 23

Kruger, 1994, Detection of polypeptides on immunoblots using secondary antibodies or protein A, Vol. 32, 215

Moorthy, 1994, Chemical structure and time dependent effects of polycyclic aromatic hydrocarbon type inducers of rat liver cytochrome P450, DNA adducts and I-compounds, Fundam Appl Toxicol, 22, 549, 10.1006/faat.1994.1062

Kang, 1992, Uptake, distribution and fate of bacterial lipopolysaccharides in monocytes and macrophages, Electron Microsc Rev, 5, 381, 10.1016/0892-0354(92)90016-J

Darlington, 1986, Monocyte-conditioned medium, interleukin-1, and tumor necrosis factor stimulate the acute phase response in human hepatoma cells in vitro, J Cell Biol, 103, 787, 10.1083/jcb.103.3.787

Chensue, 1991, In vivo biologic and immunohistochemical analysis of interleukin-1 alpha, beta and tumor necrosis factor during experimental endotoxemia. Kinetics, Kupffer cell expression, and glucocorticoid effects, Am J Pathol, 138, 395

Strieter, 1988, Cellular and molecular regulation of tumor necrosis factor-alpha production by pentoxifylline, Biochem Biophys Res Commun, 155, 1230, 10.1016/S0006-291X(88)81271-3

Doherty, 1991, Pentoxifylline suppression of tumor necrosis factor gene transcription, Surgery, 110, 192

Beaty, 1994, Lipopolysaccharide-induced cytokine production in human monocytes, Eur J Immunol, 24, 1278, 10.1002/eji.1830240606

D’Hellencourt, 1996, Differential regulation of TNF-α, IL-β, IL-6, IL-8, TNF-β and IL-10 by pentoxifylline, Int J Immunopharmacol, 18, 739, 10.1016/S0192-0561(97)85556-7

Marsden, 1990, Tumor necrosis factor α activates soluble guanylate cyclase in bovine glomerular mesangial cells via an l-arginine-dependent mechanism, J Exp Med, 172, 1843, 10.1084/jem.172.6.1843

Beasley, 1994, Interleukin-1β and tumor necrosis factor-α synergistically induce NO synthase in rat vascular smooth muscle cells, Am J Physiol, 266, R1197

Geller, 1994, Differential induction of nitric oxide synthase in hepatocytes during endotoxemia and the acute phase response, Arch Surg, 129, 165, 10.1001/archsurg.1994.01420260061008

Xie, 1994, Role of transcription factor NF-κB/Rel in induction of nitric oxide synthase, J Biol Chem, 269, 4705, 10.1016/S0021-9258(17)37600-7

Wink, 1993, Inhibition of cytochrome P450 by nitric oxide and a nitric oxide-releasing agent, Arch Biochem Biophys, 33, 115, 10.1006/abbi.1993.1016

Stadler, 1994, Inhibition of cytochromes P450IA by nitric oxide, Proc Natl Acad Sci USA, 91, 3559, 10.1073/pnas.91.9.3559

Khatsenko, 1993, Nitric oxide is a mediator of the decrease in cytochrome P450-dependent metabolism by immunostimulants, Proc Natl Acad Sci USA, 90, 11147, 10.1073/pnas.90.23.11147